Alzheimer's Research and Therapy, 1758-9193

Journal

More filtering options
  1. 2017
  2. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Lautner, R., Philip S. Insel, Skillbäck, T., Olsson, B., Landén, M., Frisoni, G. B., Herukka, S-K., Hampel, H., Wallin, A., Lennart Minthon, Oskar Hansson, Blennow, K., Niklas Mattsson & Zetterberg, H. 2017 Oct 23 In : Alzheimer's Research and Therapy. 9, 1, 87

    Research output: Contribution to journalArticle

  3. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

    Vanderstichele, H., Demeyer, L., Shorena Janelidze, Coart, E., Stoops, E., Mauroo, K., Herbst, V., François, C. & Oskar Hansson 2017 Jun 6 In : Alzheimer's Research and Therapy. 9, 1, 40

    Research output: Contribution to journalArticle

  4. 2016
  5. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

    Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Oskar Hansson, Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C. & Blennow, K. 2016 Oct 3 In : Alzheimer's Research & Therapy. 8, 1, 10 p.

    Research output: Contribution to journalArticle

  6. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

    Henjum, K., Almdahl, I. S., Årskog, V., Lennart Minthon, Oskar Hansson, Fladby, T. & Nilsson, L. N. G. 2016 In : Alzheimer's Research & Therapy. 8, 1, 182

    Research output: Contribution to journalArticle

  7. 2015
  8. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

    Kvartsberg, H., Portelius, E., Andreasson, U., Brinkmalm, G., Hellwig, K., Lelental, N., Kornhuber, J., Oskar Hansson, Lennart Minthon, Spitzer, P., Maler, J. M., Zetterberg, H., Blennow, K. & Lewczuk, P. 2015 In : Alzheimer's Research & Therapy. 7, 1, 40

    Research output: Contribution to journalArticle

  9. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

    Jekel, K. , Damian, M. , Wattmo, C. , Hausner, L. , Bullock, R. , Connelly, P. J. , Dubois, B. , Eriksdotter, M. , Ewers, M. , Graessel, E. , Kramberger, M. G. , Law, E. , Mecocci, P. , Molinuevo, J. L. , Nygård, L. , Olde-Rikkert, M. G. , Orgogozo, J-M. , Pasquier, F. , Peres, K. , Salmon, E. & 6 others Sikkes, S. A., Sobow, T., Spiegel, R., Tsolaki, M., Winblad, B. & Frölich, L. 2015 In : Alzheimer's Research & Therapy. 7, 1, 17

    Research output: Contribution to journalReview article

  10. 2014
  11. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

    Oskar Hansson, Sara Hall, Ohrfelt, A., Zetterberg, H., Blennow, K., Lennart Minthon, Katarina Nägga, Elisabet Londos, Varghese, S., Majbour, N. K., Al-Hayani, A. & El-Agnaf, O. M. 2014 In : Alzheimer's Research & Therapy. 6, 3, 25

    Research output: Contribution to journalArticle

  12. 2013
  13. Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

    Carina Wattmo, Jedenius, E., Blennow, K. & Åsa Wallin 2013 In : Alzheimer's Research & Therapy. 5, 1, 2

    Research output: Contribution to journalArticle

  14. Plasma tau levels in Alzheimer's disease

    Zetterberg, H., Wilson, D., Andreasson, U., Lennart Minthon, Blennow, K., Randall, J. & Oskar Hansson 2013 In : Alzheimer's Research & Therapy. 5, 2, 9

    Research output: Contribution to journalLetter